New Jersey, BioNJ is a powerful network of 400 Member companies representing research-based life sciences companies and stakeholders. Because Patients Can’t Wait®, we are dedicated to propelling the rich innovation ecosystem in the New Jersey region to stimulate and support innovation, improve and save lives, and lower the hurdles of healthcare advancements for society. As the industry’s voice in New Jersey, we fulfill our mission by ensuring that:
- Science is Supported
- Companies are Created
- Drugs are Developed
- Patients are Paramount
Overview
Mentions in press and media 17
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 10, 2025 | Rx Bandz Wins Two Top Awards at BIONJ Conference | Best Company Presentation Award winner Jessica Walsh, CEO, RX Bandz (center); joined by (from left) Alan Zaccone, Biotech & Pharma, CoreWeave; Kathleen Addison, Life Sciences, J.P. Morgan; Taryn Bostjancic, Life Sciences Services, Withu... |
| May 6, 2024 | Soligenix to Present at Upcoming Conferences | PRINCETON, N.J., May 6, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet... |
| Mar 7, 2023 | BioNJ Announces Lineup for BioPartnering Conference | TRENTON, N.J., March 7, 2023 /PRNewswire/ -- BioNJ is pleased to host its 13th Annual BioPartnering Conference on Tuesday, April 18, 2023, at The Palace at Somerset Park, Somerset, NJ. Back in person after three years, the Conference will b... |
| Sep 27, 2022 | BioNJ Announces the Launch of Its Health Equity in Clinical Trials Initiative | TRENTON, N.J. , Sept. 27, 2022 /PRNewswire/ -- BioNJ, the voice of the life sciences industry in New Jersey, announced the launch of its Health Equity in Clinical Trials Initiative. Committed to the vision of Health Equity for All, BioNJ's ... |
| May 11, 2021 | VYANT BIO, INC. Vyant Bio to Present at BioNJ's 11th Annual BioPartnering Conference | CHERRY HILL, N.J., May 11, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is a new force in drug discovery, focused on integrating human-powered scientific and technology-based systems to de-risk and accel... |
| May 4, 2021 | CALADRIUS BIOSCIENCES, INC. Caladrius Biosciences : Announces Participation in Upcoming Virtual Conferences in May 2021 | BASKING RIDGE, N.J., May 04, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to rever... |
| Apr 22, 2021 | BioNJ Announces Company Presenters for BioPartnering Conference | |
| Mar 3, 2021 | BioNJ Announces Diversity, Equity & Inclusion Conference Program | |
| Jun 5, 2013 | What will closer ties to payers mean for pharma? | In a recent interview with life science investor Steven Burrill, CEO of Burrill & Co, who is keynoting the annual personalized medicine conference by BioNJ this week, stressed that many more changes lay ahead for an industry that he see... |
Reviews 0
FAQ about BioNJ
When was BioNJ founded?
BioNJ was founded in 1994.
What has the press written about BioNJ?
Parsers VC has collected 17 articles mentioning BioNJ, among them “Rx Bandz Wins Two Top Awards at BIONJ Conference” (Jun 10, 2025) and “Soligenix to Present at Upcoming Conferences” (May 6, 2024).
Is BioNJ still active?
Yes, BioNJ is active; its latest activity on Parsers VC dates from Apr 30, 2026.